Option Care Health, Inc. $OPCH Shares Sold by Westfield Capital Management Co. LP

Westfield Capital Management Co. LP lessened its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 9.9% in the third quarter, HoldingsChannel.com reports. The firm owned 2,757,858 shares of the company’s stock after selling 303,616 shares during the quarter. Westfield Capital Management Co. LP’s holdings in Option Care Health were worth $76,558,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Durable Capital Partners LP increased its holdings in Option Care Health by 134.2% in the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock valued at $267,557,000 after buying an additional 4,720,988 shares in the last quarter. Norges Bank acquired a new stake in shares of Option Care Health in the 2nd quarter worth approximately $69,932,000. Swedbank AB acquired a new stake in shares of Option Care Health in the 3rd quarter worth approximately $49,455,000. Arrowstreet Capital Limited Partnership increased its stake in Option Care Health by 109.0% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,410,394 shares of the company’s stock valued at $110,770,000 after purchasing an additional 1,778,279 shares in the last quarter. Finally, Jennison Associates LLC raised its holdings in Option Care Health by 145.6% during the second quarter. Jennison Associates LLC now owns 2,138,248 shares of the company’s stock worth $69,450,000 after purchasing an additional 1,267,660 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft upped their target price on Option Care Health from $31.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, December 9th. Truist Financial set a $40.00 price objective on shares of Option Care Health in a research note on Tuesday, January 13th. Citizens Jmp restated a “market outperform” rating and set a $38.00 target price (up from $36.00) on shares of Option Care Health in a report on Tuesday, January 13th. National Bank Financial set a $37.00 price target on shares of Option Care Health in a report on Tuesday, January 27th. Finally, Citigroup reiterated an “outperform” rating on shares of Option Care Health in a research report on Tuesday, January 13th. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $37.58.

Option Care Health Trading Down 0.6%

Option Care Health stock opened at $33.60 on Thursday. The stock has a 50-day moving average price of $34.00 and a 200 day moving average price of $30.53. Option Care Health, Inc. has a 52 week low of $24.24 and a 52 week high of $36.80. The stock has a market cap of $5.33 billion, a PE ratio of 26.25, a P/E/G ratio of 2.02 and a beta of 0.84. The company has a current ratio of 1.53, a quick ratio of 1.05 and a debt-to-equity ratio of 0.87.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Tuesday, February 24th. The company reported $0.46 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.46. The company had revenue of $1.47 billion for the quarter, compared to analysts’ expectations of $1.46 billion. Option Care Health had a net margin of 3.67% and a return on equity of 18.57%. The firm’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same period last year, the company earned $0.44 EPS. Equities research analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.